ecancermedicalscience

Case Report

Pregnant with metastatic neuroendocrine tumour of the ovary: what now?

3 Jan 2012
B Pistilli, CM Grana, N Fazio, A Cavaliere, ME Ferrari, L Bodei, SM Baio, G Scambia, G Paganelli, FA Peccatori

Neuroendocrine tumours (NET) are a heterogeneous group of neoplasms commonly occurring in the gastrointestinal tract or lungs but can occur in other regions. Primary ovarian NET account for 5% of all NET and 0.1% of all ovarian malignancies. In metastatic disease, the therapeutic goal is to extend survival and to improve quality of life. As these tumours express somatostatin receptors, somatostatin analogues are frequently used to control symptoms. Here we present a case of a pregnant woman with an ovarian NET with liver metastases and carcinoid syndrome who was treated with the somatostatin analogue, Octreotide LAR. We also summarize reported data of the use of somatostatin analogues during pregnancy.

Related Articles

Adeyemi Adebola Okunowo, Aloy Okechukwu Ugwu, Azeezat Oluwafunmilayo Ajose, Jubril Oladapo Kuku, Bolanle Olajumoke Okunowo, Nneoma Kwemtochukwu Ani-Ugwu, Benedetto Oluwaseun Osunwusi, Muisi Alli Adenekan, Adaiah Priscillia Soibi-Harry, Sunusi Rimi Garba
Julius O Maitanmi, Temidara E Fabiyi, Oluwadara Eniola, Toluwalope O Sansi, Josiah O Blessing, Bukola Maitanmi, Margaret O Ojewale, Abiodun A Dairo, Damilola A Adebiyi, Oluwadamilare Akingbade
Lucky E Tietie, Kehinde S Okunade, Adaiah P Soibl-Harry, Sarah O John-Olabode, Rose I Anorlu
Annie Kanchan Baa, Sameer Rastogi, Sanal Fernandes, Shakti Shrivastava, Rajni Yadav, Adarsh Barwad, Shamim A Shamim, Nihar Ranjan Dash
Arunangshu Ghoshal, Anjum Khan Joad, Odette Spruijt, Shobha Nair, MR Rajagopal, Firuza Patel, Anuja Damani, Jayita Deodhar, Dinesh Goswami, Geeta Joshi, Savita Butola, Charu Singh, Seema Rajesh Rao, Madhura Bhatwadekar, Mary Ann Muckaden, Sushma Bhatnagar